StockDrifts LogoStockDrifts

Angio Lab 251280

Company
안지오랩Angio Lab
Insiders
1
Buys
34
Total Value
₩42M ($29K)
Avg Return
-31.82%
Last Filing
2024-04-25

Angio Lab (251280) has 34 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩42M ($29K) in reported transaction value. The earliest filing StockDrifts holds for Angio Lab is dated 2024-03-20; the most recent is 2024-04-25. Across these filings the average return since disclosure is -31.82%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-09-08BUYMarket Buy
김민영
Minyoung Kim
CEO1.4K₩3,295+7.6%₩4M ($3K)
2026-09-04BUYMarket Buy
김민영
Minyoung Kim
CEO604---
2026-09-01BUYMarket Buy
김민영
Minyoung Kim
CEO4.5K---
2026-08-27BUYMarket Buy
김민영
Minyoung Kim
CEO1.8K₩2,590+0.4%₩6M ($4K)
2026-08-26BUYMarket Buy
김민영
Minyoung Kim
CEO3.0K₩3,045-14.6%₩10M ($7K)
2026-08-25BUYMarket Buy
김민영
Minyoung Kim
CEO2.2K₩3,045-14.6%₩6M ($4K)
2026-08-24BUYMarket Buy
김민영
Minyoung Kim
CEO1.3K₩3,045-14.6%₩3M ($2K)
2026-08-21BUYMarket Buy
김민영
Minyoung Kim
CEO1.9K₩3,000+6.7%₩5M ($3K)
2026-08-20BUYMarket Buy
김민영
Minyoung Kim
CEO2.5K₩2,640+25.0%₩6M ($4K)
2026-08-19BUYMarket Buy
김민영
Minyoung Kim
CEO3.7K₩2,450+34.7%₩8M ($5K)
2026-08-11BUYMarket Buy
김민영
Minyoung Kim
CEO1.6K₩1,795+18.4%₩3M ($2K)
2026-08-06BUYMarket Buy
김민영
Minyoung Kim
CEO9.7K₩1,900+11.8%₩20M ($14K)
2024-04-25BUYMarket Buy
이태식
Taesik Lee
Planning Director127₩6,090-59.4%₩773K ($537)
2024-04-25BUYMarket Buy
이태식
Taesik Lee
Planning Director123₩6,090-59.4%₩749K ($520)
2024-04-03BUYMarket Buy
이태식
Taesik Lee
Planning Director7₩3,750-34.0%₩26K ($18)
2024-04-03BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,750-34.0%₩38K ($26)
2024-04-03BUYMarket Buy
이태식
Taesik Lee
Planning Director33₩3,750-34.0%₩124K ($86)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director40₩4,000-38.1%₩160K ($111)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director21₩4,000-38.1%₩84K ($58)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director60₩4,000-38.1%₩240K ($167)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director59₩4,000-38.1%₩236K ($164)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director15₩4,000-38.1%₩60K ($42)
2024-04-02BUYMarket Buy
이태식
Taesik Lee
Planning Director5₩4,000-38.1%₩20K ($14)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director20₩3,495-29.2%₩70K ($49)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director3₩3,495-29.2%₩10K ($7)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director57₩3,495-29.2%₩199K ($138)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director58₩3,495-29.2%₩203K ($141)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-26BUYMarket Buy
이태식
Taesik Lee
Planning Director10₩3,495-29.2%₩35K ($24)
2024-03-22BUY장외매수
이태식
Taesik Lee
Planning Director20.3K₩3,700-33.1%₩75M ($52K)
2024-03-22BUY장외매수
이태식
Taesik Lee
Planning Director20.6K₩3,700-33.1%₩76M ($53K)
2024-03-21BUYMarket Buy
이태식
Taesik Lee
Planning Director300₩3,495-29.2%₩1M ($728)
2024-03-21BUYMarket Buy
이태식
Taesik Lee
Planning Director601₩3,495-29.2%₩2M ($1K)
2024-03-21BUYMarket Buy
이태식
Taesik Lee
Planning Director1₩3,495-29.2%₩3K ($2)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director100₩3,295-24.9%₩330K ($229)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director108₩3,295-24.9%₩356K ($247)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director339₩3,295-24.9%₩1M ($776)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director5.0K₩3,295-24.9%₩16M ($11K)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director188₩3,295-24.9%₩619K ($430)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director2.0K₩3,295-24.9%₩7M ($5K)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director460₩3,295-24.9%₩2M ($1K)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director1.7K₩3,295-24.9%₩6M ($4K)
2024-03-20BUYMarket Buy
이태식
Taesik Lee
Planning Director1.0K₩3,295-24.9%₩3M ($2K)

Frequently asked questions

Who has been buying Angio Lab stock?
1 distinct insiders have filed 34 disclosed insider purchases in Angio Lab (251280), most recently on 2024-04-25. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Angio Lab have?
Angio Lab has 34 buy-side and 0 sell-side disclosures on record, covering ₩42M ($29K) in total reported value, spanning 2024-03-20 to 2024-04-25.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.